{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:16:57Z","timestamp":1793459817000,"version":"4.5.0"},"reference-count":72,"publisher":"BMJ","issue":"8","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21534008"],"award-info":[{"award-number":["21534008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400811"],"award-info":[{"award-number":["81400811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Project of Health and Family Planning Commission of Sichuan Province","award":["130029"],"award-info":[{"award-number":["130029"]}]},{"name":"Scientific Research Project of Health and Family Planning Commission of Sichuan Province","award":["150149"],"award-info":[{"award-number":["150149"]}]},{"name":"Scientific Research Project of Health and Family Planning Commission of Sichuan Province","award":["17PJ063"],"award-info":[{"award-number":["17PJ063"]}]},{"name":"Scientific Research Project of Health and Family Planning Commission of Sichuan Province","award":["17PJ445"],"award-info":[{"award-number":["17PJ445"]}]},{"name":"The International Visiting Program for Excellent Young Scholars of Sichuan University"},{"name":"Cholesterol Fund by China Cardiovascular Foundation and China Heart House"},{"name":"Talents Cultivation Fund of West China Hospital"},{"name":"The BigData@Heart Consortium"},{"name":"1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University","award":["ZYGD18022"],"award-info":[{"award-number":["ZYGD18022"]}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2015CB942800"],"award-info":[{"award-number":["2015CB942800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sichuan Science and Technology Program","award":["2019YFH0150"],"award-info":[{"award-number":["2019YFH0150"]}]},{"name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre"},{"DOI":"10.13039\/501100023699","name":"Health Data Research UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023699","id-type":"DOI","asserted-by":"crossref"}]},{"name":"THIN institute postdoctoral fellowship"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,7,23]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Despite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the quality and consistency of guidance documents for gout and hyperuricemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and quality assessment using the appraisal of guidelines for research and evaluation (AGREE) II methodology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>PubMed and EMBASE (27 October 2016), two Chinese academic databases, eight guideline databases, and Google and Google scholar (July 2017).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>We included the latest version of international and national\/regional clinical practice guidelines and consensus statements for diagnosis and\/or treatment of hyperuricemia and gout, published in English or Chinese.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Two reviewers independently screened searched items and extracted data. Four reviewers independently scored documents using AGREE II. Recommendations from all documents were tabulated and visualised in a coloured grid.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-four guidance documents (16 clinical practice guidelines and 8 consensus statements) published between 2003 and 2017 were included. Included documents performed well in the domains of scope and purpose (median 85.4%, range 66.7%\u2013100.0%) and clarity of presentation (median 79.2%, range 48.6%\u201398.6%), but unsatisfactory in applicability (median 10.9%, range 0.0%\u201366.7%) and editorial independence (median 28.1%, range 0.0%\u201383.3%). The 2017 British Society of Rheumatology guideline received the highest scores. Recommendations were concordant on the target serum uric acid level for long-term control, on some indications for urate-lowering therapy (ULT), and on the first-line drugs for ULT and for acute attack. Substantially inconsistent recommendations were provided for many items, especially for the timing of initiation of ULT and for treatment for asymptomatic hyperuricemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Methodological quality needs improvement in guidance documents on gout and hyperuricemia. Evidence for certain clinical questions is lacking, despite numerous trials in this field. Promoting standard guidance development methods and synthesising high-quality clinical evidence are potential approaches to reduce recommendation inconsistencies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42016046104.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-026677","type":"journal-article","created":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T10:45:15Z","timestamp":1566643515000},"page":"e026677","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":161,"title":["Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements"],"prefix":"10.1136","volume":"9","author":[{"given":"Qianrui","family":"Li","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Institute of Health Informatics, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oto-Rhino-Laryngology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongdie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey Sum-Wing","family":"Kwong","sequence":"additional","affiliation":[{"name":"Jockey Club School of Public Health and Primary Care, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[{"name":"The Second Clinical College, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[{"name":"Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Chia","family":"Chung","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Shah","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, University College London, London, UK"},{"name":"Farr Institute of Health Informatics Research, University College London, London, UK"},{"name":"Health Data Research UK London, University College London, London, UK"},{"name":"The National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaolong","family":"Chen","sequence":"additional","affiliation":[{"name":"Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenmei","family":"An","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[{"name":"Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2279-0624","authenticated-orcid":false,"given":"Harry","family":"Hemingway","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, University College London, London, UK"},{"name":"Health Data Research UK London, University College London, London, UK"},{"name":"The National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0060-0287","authenticated-orcid":false,"given":"Sheyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Division of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,8,24]]},"reference":[{"key":"2025121400024109000_9.8.e026677.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23176"},{"key":"2025121400024109000_9.8.e026677.2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/690690"},{"key":"2025121400024109000_9.8.e026677.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.91"},{"key":"2025121400024109000_9.8.e026677.4","first-page":"2690","article-title":"March L: Global prevalence of hyperuricemia: a systematic review of population-based epidemiological studies","volume":"67","author":"Smith","year":"2015","journal-title":"Arthritis & Rheumatology"},{"key":"2025121400024109000_9.8.e026677.5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204647"},{"key":"2025121400024109000_9.8.e026677.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204463"},{"key":"2025121400024109000_9.8.e026677.7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j2376","article-title":"Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies","volume":"357","author":"Li","year":"2017","journal-title":"BMJ"},{"key":"2025121400024109000_9.8.e026677.8","first-page":"549","article-title":"Gout--current diagnosis and treatment","volume":"106","author":"Tausche","year":"2009","journal-title":"Dtsch Arztebl Int"},{"key":"2025121400024109000_9.8.e026677.9","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.69.8.594"},{"key":"2025121400024109000_9.8.e026677.10","first-page":"1799","article-title":"Diagnosis and management of gout","volume":"59","author":"Pittman","year":"1999","journal-title":"Am Fam Physician"},{"key":"2025121400024109000_9.8.e026677.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.23007"},{"key":"2025121400024109000_9.8.e026677.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.22767"},{"key":"2025121400024109000_9.8.e026677.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j5158","article-title":"Clinical practice guidelines in China","volume":"360","author":"Chen","year":"2018","journal-title":"BMJ"},{"key":"2025121400024109000_9.8.e026677.14","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21772"},{"key":"2025121400024109000_9.8.e026677.15","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21773"},{"key":"2025121400024109000_9.8.e026677.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"2025121400024109000_9.8.e026677.17","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.11.2511"},{"key":"2025121400024109000_9.8.e026677.18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055251"},{"key":"2025121400024109000_9.8.e026677.19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7326\/M16-0569","article-title":"Diagnosis of acute gout: a clinical practice guideline from the American College of physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"key":"2025121400024109000_9.8.e026677.20","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0570"},{"key":"2025121400024109000_9.8.e026677.21","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/rheumatology\/kex150","article-title":"The British Society for rheumatology guideline for the management of gout","volume":"56","author":"Hui","year":"2017","journal-title":"Rheumatology"},{"key":"2025121400024109000_9.8.e026677.22","first-page":"235","article-title":"[Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases]","volume":"56","year":"2017","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2025121400024109000_9.8.e026677.23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/M16-2426","article-title":"The long and winding road to clinical guidelines on the diagnosis and management of gout","volume":"166","author":"McLean","year":"2017","journal-title":"Ann Intern Med"},{"key":"2025121400024109000_9.8.e026677.24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrrheum.2012.216","article-title":"New ACR guidelines for gout management hold some surprises","volume":"9","author":"Bardin","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"2025121400024109000_9.8.e026677.25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrrheum.2017.126","article-title":"Discordant American College of physicians and international rheumatology guidelines for gout management: consensus statement of the gout, hyperuricemia and Crystal-Associated disease network (G-CAN)","volume":"13","author":"Dalbeth","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2025121400024109000_9.8.e026677.26","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000154"},{"key":"2025121400024109000_9.8.e026677.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014928","article-title":"Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements","volume":"7","author":"Li","year":"2017","journal-title":"BMJ Open"},{"key":"2025121400024109000_9.8.e026677.28","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"2025121400024109000_9.8.e026677.29","first-page":"38-47","article-title":"Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain","volume":"160","author":"Nuckols","year":"2014","journal-title":"Ann Intern Med"},{"key":"2025121400024109000_9.8.e026677.30","doi-asserted-by":"crossref","DOI":"10.1186\/s12871-015-0150-5","article-title":"Clinical practice guidelines for the management of neuropathic pain: a systematic review","volume":"16","author":"Deng","year":"2016","journal-title":"BMC Anesthesiol"},{"key":"2025121400024109000_9.8.e026677.31","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-191","article-title":"Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer","volume":"11","author":"Huang","year":"2013","journal-title":"BMC Med"},{"key":"2025121400024109000_9.8.e026677.32","doi-asserted-by":"publisher","DOI":"10.1002\/art.24207"},{"key":"2025121400024109000_9.8.e026677.33","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-014-0231-1","article-title":"Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements","volume":"12","author":"Nagler","year":"2014","journal-title":"BMC Med"},{"key":"2025121400024109000_9.8.e026677.34","unstructured":"Agree II training tools. Available: http:\/\/www.agreetrust.org-resource-centre-agree-ii-training-tooles\/ [Accessed Aug 01 2017]."},{"key":"2025121400024109000_9.8.e026677.35","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.091714"},{"key":"2025121400024109000_9.8.e026677.36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203325"},{"key":"2025121400024109000_9.8.e026677.37","first-page":"913","article-title":"Chinese consensus on the management of hyperuricemia and gout","volume":"29","year":"2013","journal-title":"Chin J Endocrinol Metab"},{"key":"2025121400024109000_9.8.e026677.38","first-page":"1","article-title":"Taiwan guideline for the management of gout and hyperuricemia - updated 2016","volume":"30","year":"2016","journal-title":"F J Rheumatol"},{"key":"2025121400024109000_9.8.e026677.39","doi-asserted-by":"crossref","unstructured":"Kiltz U , Smolen J , Bardin T , et al . (T2T) recommendations for gout. Ann Rheum Dis 2016;76.","DOI":"10.1136\/annrheumdis-2016-209467"},{"key":"2025121400024109000_9.8.e026677.40","first-page":"158","article-title":"Portuguese recommendations for the diagnosis and management of gout","volume":"39","author":"Ara\u00fajo","year":"2014","journal-title":"Acta Reumatol Port"},{"key":"2025121400024109000_9.8.e026677.41","first-page":"892","article-title":"2016 Chinese guideline on the diagnosis and management of gout","volume":"55","year":"2016","journal-title":"Chin J Intern Med"},{"key":"2025121400024109000_9.8.e026677.42","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208237"},{"key":"2025121400024109000_9.8.e026677.43","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12557"},{"key":"2025121400024109000_9.8.e026677.44","unstructured":"Federal Ministry of Health (Nigeria) . National nutritional guideline on non-communicable disease prevention, control and management. Available: http:\/\/www.health.gov.ng\/doc\/NutritionalGuideline.pdf [Accessed 28 Jul 2017]."},{"key":"2025121400024109000_9.8.e026677.45","first-page":"4","article-title":"Italian Society of rheumatology recommendations for the management of gout","volume":"65","author":"Manara","year":"2013","journal-title":"Reumatismo"},{"key":"2025121400024109000_9.8.e026677.46","unstructured":"Spanish Society of Rheumatology (SER) . Clinical practice guidelines for management of gout. Available: https:\/\/www.ser.es\/wp-content\/uploads\/2015\/09\/GuipClinGot_1140226_EN.pdf [Accessed 28 Jul 2017]."},{"key":"2025121400024109000_9.8.e026677.47","first-page":"241","article-title":"The diagnosis and treatment advice of cardiovascular disease combined asymptomatic hyperuricemia (second edition)","volume":"10","author":"Hu","year":"2012","journal-title":"Chin J Cardiovas Res"},{"key":"2025121400024109000_9.8.e026677.48","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2011.596496"},{"key":"2025121400024109000_9.8.e026677.49","unstructured":"Ministry of Health Malaysia (MOH) . Management of gout. Available: http:\/\/www.moh.gov.my\/penerbitan\/CPG2017\/3893.pdf [Accessed 28 July 2017]."},{"key":"2025121400024109000_9.8.e026677.50","unstructured":"Li-Yu J , Salido E , Manahan S , et al . Philippine clinical practice guidelines for the management of gout. Int J Rheum Dis"},{"key":"2025121400024109000_9.8.e026677.51","first-page":"961","article-title":"Hyperuricaemia and gout: clinical guideline 2003","volume":"93","author":"Meyers","year":"2003","journal-title":"S Afr Med J"},{"key":"2025121400024109000_9.8.e026677.52","unstructured":"Management of initial gout in adults. The University of Texas at Austin, school of nursing, family nurse practitioner program. Available: http:\/\/www.alabmed.com\/uploadfile\/2014\/0515\/20140515070230703.pdf [Accessed 25 July 2017]."},{"key":"2025121400024109000_9.8.e026677.53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7183.593"},{"key":"2025121400024109000_9.8.e026677.54","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.4103\/0366-6999.216416","article-title":"Chinese multidisciplinary expert consensus on the diagnosis and treatment of hyperuricemia and related diseases","volume":"130","year":"2017","journal-title":"Chin Med J"},{"key":"2025121400024109000_9.8.e026677.55","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/1756-185X.13266","article-title":"Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan","volume":"21","author":"Yu","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2025121400024109000_9.8.e026677.56","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000034"},{"key":"2025121400024109000_9.8.e026677.57","doi-asserted-by":"crossref","unstructured":"Wang D , Yu Y , Chen Y , et al . Assessing the quality of global clinical practice guidelines on gout using agree II instrument. J Clin Rheumatol 2018.doi:10.1097\/RHU.0000000000000921","DOI":"10.1097\/RHU.0000000000000921"},{"key":"2025121400024109000_9.8.e026677.58","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055269"},{"key":"2025121400024109000_9.8.e026677.59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058625","article-title":"Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus","volume":"8","author":"Holmer","year":"2013","journal-title":"PLoS One"},{"key":"2025121400024109000_9.8.e026677.60","doi-asserted-by":"publisher","DOI":"10.1177\/1062860615574863"},{"key":"2025121400024109000_9.8.e026677.61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12020-018-1535-2","article-title":"Appraisal of clinical practice guidelines on the management of hypothyroidism in pregnancy using the appraisal of guidelines for research and evaluation II instrument","volume":"60","author":"Fang","year":"2018","journal-title":"Endocrine"},{"key":"2025121400024109000_9.8.e026677.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.07.005"},{"key":"2025121400024109000_9.8.e026677.63","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/acr.23185","article-title":"\u201cOfficial view\u201d on glucocorticoids in rheumatoid arthritis: a systematic review of international guidelines and consensus statements","volume":"69","author":"Palmowski","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2025121400024109000_9.8.e026677.64","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/acr.22591","article-title":"Diagnosis, monitoring, and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines","volume":"67","author":"Tunnicliffe","year":"2015","journal-title":"Arthritis Care Res"},{"key":"2025121400024109000_9.8.e026677.65","doi-asserted-by":"crossref","unstructured":"Alonso-Coello P , Irfan A , Sol\u00e0 I , et al . The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Qual Saf Health Care 2010;19.doi:10.1136\/qshc.2010.042077","DOI":"10.1136\/qshc.2010.042077"},{"key":"2025121400024109000_9.8.e026677.66","doi-asserted-by":"publisher","DOI":"10.1159\/000077906"},{"key":"2025121400024109000_9.8.e026677.67","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jhep.2017.06.028","article-title":"Evaluation of the current guidelines for resection of hepatocellular carcinoma using the appraisal of guidelines for research and evaluation II instrument","volume":"67","author":"Gavriilidis","year":"2017","journal-title":"J Hepatol"},{"key":"2025121400024109000_9.8.e026677.68","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.semarthrit.2016.10.009","article-title":"The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States","volume":"46","author":"Jutkowitz","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2025121400024109000_9.8.e026677.69","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/rheumatology\/kex253","article-title":"Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout","volume":"56","author":"Plumpton","year":"2017","journal-title":"Rheumatology"},{"key":"2025121400024109000_9.8.e026677.70","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-5-201203060-00009"},{"key":"2025121400024109000_9.8.e026677.71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095369","article-title":"A systematic critical appraisal of non-pharmacological management of rheumatoid arthritis with appraisal of guidelines for research and evaluation II","volume":"9","author":"Brosseau","year":"2014","journal-title":"PLoS One"},{"key":"2025121400024109000_9.8.e026677.72","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.056952"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-026677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:02:53Z","timestamp":1765699373000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-026677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":72,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,24]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/bmjopen-2018-026677"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-026677","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}